Tepnel to Provide DNA-Extraction Services for AstraZeneca

May 04, 2006

NEW YORK, May 4 (GenomeWeb News) - Tepnel Life Sciences said today that it has signed a global agreement to provide DNA-extraction services for AstraZeneca.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Danaher Q2 Revenues Grow 6 Percent; MDx Product Line Shut Down
Abbott Dx Revenues Rise 4 Percent in Q2 on Strong Core Lab and Point-of-Care Growth
UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research
Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech
Integrated Medulloblastoma Genomics Study Reveals Refined View of Tumor Subtypes
3D Signatures Files to Offer C$5M in Common Stock

The Scan

Persistent Gap

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

Puppies' Past

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

This Week in Genome Research

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Testing for Complications

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.

Main menu